Long Term Follow-Up of Diabetic Retinopathy

Launched by NATIONAL EYE INSTITUTE (NEI) · Dec 9, 2002

Keywords

ClinConnect Summary

The efficacy of laser photocoagulation treatment for diabetic retinopathy has been demonstrated by several National Eye Institute (NEI) sponsored clinical trials. The Diabetic Retinopathy Study (DRS) demonstrated that scatter photocoagulation reduces the risk of blindness from diabetic retinopathy. The Early Treatment Diabetic Retinopathy Study (ETDRS) extended these findings by providing information on when to initiate scatter photocoagulation and by demonstrating that focal treatment was effective in treating macula edema. The Krypton Argon Regression Neovascularization Study (KARNS) show...

Gender

ALL

Eligibility criteria

• • All patients with diabetic retinopathy that has been treated previously with laser photocoagulation, either focal or scatter treatment, are eligible.
• • Patients must be 18 or more years of age.
• • Patients who have not had laser photocoagulation for diabetic retinopathy are not eligible for the study.